Last 21,050 KRW
Change Today +250.00 / 1.20%
Volume 29.1K
As of 1:18 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

daihan pharmaceutical co ltd (023910) Snapshot

Open
20,800
Previous Close
20,800
Day High
21,150
Day Low
20,500
52 Week High
10/23/14 - 23,200
52 Week Low
06/5/14 - 16,050
Market Cap
126.3B
Average Volume 10 Days
32.8K
EPS TTM
1,637
Shares Outstanding
6.0M
EX-Date
12/29/14
P/E TM
12.9x
Dividend
150.00
Dividend Yield
0.71%
Current Stock Chart for DAIHAN PHARMACEUTICAL CO LTD (023910)

Related News

No related news articles were found.

daihan pharmaceutical co ltd (023910) Related Businessweek News

No Related Businessweek News Found

daihan pharmaceutical co ltd (023910) Details

Daihan Pharmaceutical Co., Ltd. manufactures and supplies medicinal products primarily in South Korea. It offers infusions, such as basic infusions, nutritional infusions, and infusions for special uses; and injections for anesthetics, antispasmodic, respiratory, vitamin-mineral, antidotes, autonomic nerve system, hormones, hepatic protector, hypnotic-sedative, analgesic/antirheumatic, and other areas. The company also provides external use products, including irrigations, ointments, and inhalants, as well as solutions for artificial kidney dialysis. In addition, it offers quasi-drugs; and contrast media products in the areas of CT and MRI. The company was formerly known as DAI HAN Pharmaceutical Chemistry, Co. and changed its name to Daihan Pharmaceutical Co., Ltd. in 1978. Daihan Pharmaceutical Co., Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.

Founded in 1945

daihan pharmaceutical co ltd (023910) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

daihan pharmaceutical co ltd (023910) Key Developments

Daihan Pharmaceutical Co.,Ltd., Annual General Meeting, Mar 21, 2014

Daihan Pharmaceutical Co.,Ltd., Annual General Meeting, Mar 21, 2014., at 09:00 Korea Standard Time. Location: Place in Ansan Industrial Complex. Agenda: To consider the group's financial statements for the period Jan. 01, 2013 - Dec. 31, 2013; to consider the election of Director (one person inside directors, outside directors one) Inside director candidates Yeomboksu (re- elected ) and Yimunseon outside director candidates (re- elected); to consider the Appointment of Auditor (Standing Auditor candidate Immyeonghyeok (re- elected)); to consider the approval of director remuneration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
023910:KS 21,050.00 KRW +250.00

023910 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 023910.
View Industry Companies
 

Industry Analysis

023910

Industry Average

Valuation 023910 Industry Range
Price/Earnings 12.0x
Price/Sales 1.1x
Price/Book 1.9x
Price/Cash Flow 11.7x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAIHAN PHARMACEUTICAL CO LTD, please visit www.daihan.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.